Company Biofarm S.A.

BIO

ROBIOFACNOR9

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Generic Pharmaceuticals

End-of-day quote Bucharest S.E. Other stock markets 06:00:00 2024-04-16 pm EDT			5-day change	1st Jan Change
0.818 ^RON	+1.24%		-0.97%	-0.73%

2023	Biofarm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI
2023	Biofarm S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Biofarm SA is a Romania-based company engaged in the pharmaceutical sector. The Company focuses on the production and marketing of pharmaceutical preparations. The Company is active in the manufacture and wholesale of over the counter drugs, prescription medications and dietary supplements. The Companyâs product portfolio includes pharmaceutical preparations for digestive system, musculoskeletal system, immune stimulation, respiratory system, cold and flu symptoms and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants and cosmetics, among others. Additionally, the Company offers services, such as consultancy on Romanian pharmaceutical market, manufacturing of non-sterile products, the investment in research, promotion and packaging. The main shareholder of the Company is Societatea de Investitii Financiare Muntenia SA.

Number of employees: 402

RON in Million	2021	Weight	2022	Weight	Delta
Pharmaceutical Products 100.0 %	239	100.0 %	277	100.0 %	+15.87%

RON in Million	2021	Weight	2022	Weight	Delta
Romania 100.0 %	239	100.0 %	277	100.0 %	+15.87%

Managers	Title	Age	Since
Catalin Vicol CEO	Chief Executive Officer	49	18-11-14
Mihai Zoescu DFI	Director of Finance/CFO	44	21-01-17
Lucian Bogaciu ADM	Chief Administrative Officer	50	19-12-31
Daniel Constantin IRC	Investor Relations Contact	42	19-08-18
Roxana Stanciu IRO	Public Communications Contact	-	-
Ioana Goranescu SAM	Sales & Marketing	44	19-01-20
Maria Bogde HRO	Human Resources Officer	46	05-12-31
Matei Monica Claudia AUD	Comptroller/Controller/Auditor	44	16-05-08

Members of the board	Title	Age	Since
Catalin Vicol CEO	Chief Executive Officer	49	18-11-14
Bogdan-Alexandru Dragoi BRD	Director/Board Member	43	15-12-09
Nicusor-Marian Buica BRD	Director/Board Member	49	-
Andrei Hrebenciuc CHM	Chairman	39	13-11-05
Rachid El Lakis BRD	Director/Board Member	57	19-12-10

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	985,375,350	115,039,314 ( 11.67 %)	8,126 ( 0.000825 %)	11.67 %

Name	Equities	%	Valuation
Oltenia SIF SA (Investment Management) 29.88 %	294,477,852	29.88 %	53 M lei
Evergent Investments SA (Investment Management) 14.67 %	144,598,144	14.67 %	26 M lei
Globinvest SAI SA 0.2725 %	2,685,264	0.2725 %	480 797 lei
Certinvest SA 0.1234 %	1,215,835	0.1234 %	217 695 lei
SAI Broker SA 0.1211 %	1,193,341	0.1211 %	213 668 lei
Swiss Capital Asset Management SAI SA 0.1169 %	1,151,776	0.1169 %	206 225 lei
Generali Investments LLC 0.0889 %	876,138	0.0889 %	156 873 lei
Gutmann KAG 0.0860 %	847,415	0.0860 %	151 730 lei
Karoll Capital Management Plc 0.0812 %	800,000	0.0812 %	143 240 lei
Delubac Asset Management SA 0.0345 %	340,189	0.0345 %	60 911 lei

Biofarm SA

99 Logofatul Tautu Street District 3

031212, Bucharest

+40 21 301 0600

http://www.biofarm.ro

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Generic Pharmaceuticals

	1st Jan change	Capi.
BIOFARM S.A.	-0.73%	172M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.40%	44.1B
OTSUKA HOLDINGS CO., LTD.	+17.11%	21.97B
CIPLA LIMITED	+8.10%	13.27B
SANDOZ GROUP AG	+6.58%	13.22B
ZYDUS LIFESCIENCES LIMITED	+35.95%	11.36B
ONO PHARMACEUTICAL CO., LTD.	-8.53%	7.07B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+10.09%	5.23B

Generic Pharmaceuticals